FindTrial
Sign In

Comprehensive study for surgical effect and prognosis of Tetralogy of Fallot

A single-center ambispective cohort study for surgical effect and prognostic factors of Tetralogy of Fallot after surgical repair

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033234
Enrollment
Unknown
Registered
2020-05-25
Start date
2020-06-05
Completion date
Unknown
Last updated
2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tetralogy of Fallot

Interventions

TOF AS:annlus-sparing repair
TOF TAPE:transannular patch enlargement

Sponsors

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients admitted to hospital from 2012 to 2030 who were mainly diagnosed with tetralogy of Fallot. 2.The patient or guardian agrees with the participant.

Exclusion criteria

Exclusion criteria: 1. TOF with other complicated intracardiac malformations, such as total anomalous pulmonary venous drainage, total endocardial cushion defect, pulmonary vein stenosis and so on. 2. Patients and guardians are not willing to participate in this study.

Design outcomes

Primary

MeasureTime frame
death;reintervention;pRV/pAo;PV adequacy;—

Countries

China

Contacts

Public ContactQiang Wang

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College

wq.cory@163.com+86 15699870837

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 16, 2026